P53 Mutants, DNA Medicine, and Mobile Genetic Elements

Register Link:

https://www.eventbrite.com/e/genobiotx-april-2025-webinar-tickets-1310558388419?aff=oddtdtcreator

Date:

  • Wednesday, April 23rd, 2025; 2:00 pm EDT or 11:00 am PDT

Meet Our Speaker:

Dr. Li earned his Ph.D. in Molecular Biology in 1999 from the Shanghai Institute of Biochemistry, Chinese Academy of Sciences, followed by postdoctoral training at Yale University (1999–2004). With over 20 years of experience in cancer molecular biology, Dr. Li has held faculty positions at the University of Louisville, Cleveland Clinic, and currently at Baylor College of Medicine, where he is also a CPRIT Scholar and a member of the Dan L Duncan Comprehensive Cancer Center.

A Fellow of the American Association for the Advancement of Science (AAAS), Dr. Li has authored over 210 peer-reviewed publications and received numerous honors, including the Achievement Award from the Society of American Asian Scientists in Cancer Research. His research focuses on tumor suppressor p53, mutant-specific cancer immunotherapies, DNA-encoded antibodies and vaccines, and environmental carcinogenesis. Dr. Li leads national and international collaborations aimed at developing novel strategies for cancer prevention and treatment.

About GenoBioTX

GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.

Contact us

Website: www.genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA

    News Center

    2024.11.01

    CCR8: the Next Promising Immune Checkpoint for Antitumor Drugs Development

    CCR8, as a novel immune checkpoint in tumor microenvironment, was hotly discussed during 2022 AACR conference. Since then, numerous prestigious pharmaceutical corporations have shifted their attention to CCR8, previously almost unknown. You may wonder why CCR8 gave rise to so strong interest of pharmaceutical industry. Just follow us to have a quick review of CCR8, […]

    2024.11.01

    New Service Launch: Mouse Bone Metastasis Cancer Model and Pain-Related Behavior Assessment!

    What is Bone Cancer Pain?  Cancer-induced Bone Pain (CIBP) or Bone Cancer Pain (BCP) is a type of pain caused by the invasion of tumors (such as primary bone tumors or bone metastases from breast cancer, prostate cancer, bladder cancer, lung cancer, etc.) into the bones [1]. This pain can severely impact a patient’s mental state […]

    Email Back to top